{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:54:29Z","timestamp":1784660069292,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Complexo de Centrais de Apoio a Pesquisa"},{"name":"Programa de P\u00f3s-gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas da Universidade Estadual de Maring\u00e1"},{"name":"Centre de Recherches sur les Macromol\u00e9cules V\u00e9g\u00e9tales"},{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.msec.2020.110720","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T05:52:50Z","timestamp":1580795570000},"page":"110720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"110","author":[{"given":"Juliana Kovalczuk","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Ueda-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene Gon\u00e7alves","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Fonseca Vianna","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Vataru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Auzely-Velty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2020.110720_bb0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.msec.2020.110720_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.msec.2020.110720_bb0015","series-title":"Tech. Rep. Ser. No. 975","first-page":"100","article-title":"Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis","author":"W.H.O. World Health Organization","year":"2012"},{"key":"10.1016\/j.msec.2020.110720_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085706","article-title":"A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.110720_bb0025","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.3390\/molecules17055164","article-title":"Microwave-assisted solvent-free synthesis and in vitro antibacterial screening of quinoxalines and pyrido[2, 3b]pyrazines","volume":"17","author":"Morales-Castellanos","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.msec.2020.110720_bb0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1248\/cpb.c12-01061","article-title":"Synthesis of 2,3-bis(halomethyl)quinoxaline derivatives and evaluation of their antibacterial and antifungal activities","volume":"61","author":"Ishikawa","year":"2013","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.msec.2020.110720_bb0035","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.bmcl.2011.03.042","article-title":"Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors","volume":"21","author":"You","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.msec.2020.110720_bb0040","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.bmcl.2011.02.055","article-title":"2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study","volume":"21","author":"Chen","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.msec.2020.110720_bb0045","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.bmc.2012.02.022","article-title":"Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study","volume":"20","author":"Rajule","year":"2012","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.msec.2020.110720_bb0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2013.01.038","article-title":"2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt\/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549\/Wnt2 cells","volume":"431","author":"Lee","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msec.2020.110720_bb0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.exppara.2011.01.009","article-title":"Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives","volume":"127","author":"Estevez","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.msec.2020.110720_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.11.018","article-title":"Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents","volume":"90","author":"Cogo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.msec.2020.110720_bb0065","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1128\/AAC.02582-15","article-title":"In vitro and in vivo activities of 2,3-diarylsubstituted quinoxaline derivatives against Leishmania amazonensis","volume":"60","author":"Kaplum","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.msec.2020.110720_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bmc.2006.09.068","article-title":"Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents","volume":"15","author":"Guillon","year":"2007","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.msec.2020.110720_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1590\/S0074-02762008000800006","article-title":"Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1 -(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives","volume":"103","author":"Burguete","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.msec.2020.110720_bb0080","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1016\/j.bmcl.2011.05.125","article-title":"New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities","volume":"21","author":"Barea","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.msec.2020.110720_bb0085","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.3390\/molecules18044718","article-title":"New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities","volume":"18","author":"Barea","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.msec.2020.110720_bb0090","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.msec.2020.110720_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00497-17","article-title":"Treatment of experimental visceral leishmaniasis with single-dose liposomal amphotericin B \u2013 pharmacodynamics and biodistribution at different stages of disease","volume":"61","author":"Voak","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.msec.2020.110720_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin. Emerg. Drugs."},{"key":"10.1016\/j.msec.2020.110720_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1039\/C5CS00674K","article-title":"New approaches from nanomedicine for treating leishmaniasis","volume":"45","author":"Guti\u00e9rrez","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.msec.2020.110720_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","article-title":"Application of nanotechnology in treatment of leishmaniasis: a review","volume":"172","author":"Akbari","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.msec.2020.110720_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/17425247.5.7.805","article-title":"Drug delivery systems against leishmaniasis? Still an open question","volume":"5","author":"Romero","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.msec.2020.110720_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/AAC.41.4.752","article-title":"Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis","volume":"41","author":"Yardley","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.msec.2020.110720_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","article-title":"Topical amphotericin B in ultradeformable liposomes: formulation, skin penetration study, antifungal and antileishmanial activity in vitro","volume":"139","author":"Perez","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.msec.2020.110720_bb0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","article-title":"Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice","volume":"196","author":"Kavian","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.msec.2020.110720_bb0135","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acs.molpharmaceut.5b00952","article-title":"Repeated administration of hyaluronic acid coated liposomes with improved pharmacokinetics and reduced immune response","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0140","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1016\/j.xphs.2019.06.012","article-title":"Synergistic enhancement of cellular uptake with CD44-expressing malignant pleural mesothelioma by combining cationic liposome and hyaluronic acid-lipid conjugate","volume":"108","author":"Sakurai","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jddst.2019.01.042","article-title":"Hyaluronic acid-coated solid lipid nanoparticles to overcome drug-resistance in tumor cells","volume":"50","author":"Lee","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.msec.2020.110720_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msec.2020.110720_bb0155","article-title":"Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect","volume":"53","author":"Song","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.msec.2020.110720_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2017.06.006","article-title":"Cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin inflammation","volume":"22","author":"Gimblet","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.msec.2020.110720_bb0165","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1039\/c4cc02595d","article-title":"A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis","volume":"50","author":"Shin","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.msec.2020.110720_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109766","article-title":"Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis","volume":"103","author":"Trujillo-Nolasco","year":"2019","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.msec.2020.110720_bb0175","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1002\/pola.26201","article-title":"Modification of polysaccharides via thiol-ene chemistry: a versatile route to functional biomaterials","volume":"50","author":"Mergy","year":"2012","journal-title":"J. Polym. Sci. Part A Polym. Chem."},{"key":"10.1016\/j.msec.2020.110720_bb0180","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1039\/C7NR03964F","article-title":"Coumarin-containing thermoresponsive hyaluronic acid-based nanogels as delivery systems for anticancer chemotherapy","volume":"9","author":"Stefanello","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.msec.2020.110720_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.carbpol.2014.02.070","article-title":"A systematic analysis of DMTMM vs EDC\/NHS for ligation of amines to Hyaluronan in water","volume":"108","author":"D\u2019Este","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.msec.2020.110720_bb0190","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1021\/la3045434","article-title":"Incorporation of amphiphilic cyclodextrins into liposomes as artificial receptor units","volume":"29","author":"Kauscher","year":"2013","journal-title":"Langmuir"},{"key":"10.1016\/j.msec.2020.110720_bb0195","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/mp2000428","article-title":"Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0200","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1021\/la5045865","article-title":"Association between cationic liposomes and low molecular weight hyaluronic acid","volume":"31","author":"Gasperini","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.msec.2020.110720_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nprot.2014.002","article-title":"Engineering cells with intracellular agent-loaded microparticles to control cell phenotype","volume":"9","author":"Ankrum","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.msec.2020.110720_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","article-title":"Colorimetric determination of phospholipids with ammonium ferrothiocyanate","volume":"104","author":"Stewart","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.msec.2020.110720_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2016.06.057","article-title":"Docetaxel-loaded liposomes: the effect of lipid composition and purification on drug encapsulation and in vitro toxicity","volume":"514","author":"Pereira","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00255","article-title":"Induction of early autophagic process on Leishmania amazonensis by synergistic effect of miltefosine and innovative semi-synthetic thiosemicarbazone","volume":"8","author":"Scariot","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.msec.2020.110720_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep44236","article-title":"Hydrogel increases localized transport regions and skin permeability during low frequency ultrasound treatment","volume":"7","author":"Pereira","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msec.2020.110720_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2017.09.034","article-title":"Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models","volume":"111","author":"Pra\u00e7a","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0235","series-title":"Nanostructures Eng. Cells, Tissues Organs From Des. to Appl","first-page":"135","article-title":"Nanoparticles influence in skin penetration of drugs: in vitro and in vivo characterization","author":"Lemos","year":"2018"},{"key":"10.1016\/j.msec.2020.110720_bb0240","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1520-6017(200105)90:5<545::AID-JPS1012>3.0.CO;2-H","article-title":"Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis","volume":"90","author":"Tang","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0245","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jps.22280","article-title":"Transport pathways and enhancement mechanisms within localized and non-localized transport regions in skin treated with low-frequency sonophoresis and sodium lauryl sulfate","volume":"100","author":"Polat","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0250","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1039\/c3ob41721b","article-title":"Liposome surface functionalization based on different anchoring lipids via Staudinger ligation","volume":"12","author":"Vabbilisetty","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.msec.2020.110720_bb0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/bm501613u","article-title":"Type, density, and presentation of grafted adhesion peptides on polysaccharide-based hydrogels control preosteoblast behavior and differentiation","volume":"16","author":"Jing","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.msec.2020.110720_bb0260","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","volume":"97","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5173(94)90361-1","article-title":"Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery","volume":"112","author":"Mccormack","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-2760(92)90228-N","article-title":"Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen","volume":"1127","author":"Litzinger","year":"1992","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"10.1016\/j.msec.2020.110720_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.msec.2017.02.012","article-title":"Development of a DNA-liposome complex for gene delivery applications","volume":"75","author":"Rasoulianboroujeni","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.110720_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jddst.2018.02.010","article-title":"Preparation, characterization and in vitro evaluation of calothrixin B liposomes","volume":"44","author":"Yingyuad","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.msec.2020.110720_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2020.110720_bb0290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2016.01.017","article-title":"Formulation and advantages of furazolidone in liposomal drug delivery systems","volume":"84","author":"Alam","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.110720_bb0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2020.110720_bb0305","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.bbamem.2016.02.025","article-title":"Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylation","volume":"1858","author":"Bunker","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.msec.2020.110720_bb0310","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1021\/nn405839n","article-title":"Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.msec.2020.110720_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0378-5173(97)00406-7","article-title":"Administration of liposomal agents and the phagocytic function of the mononuclear phagocyte system","volume":"162","author":"van Etten","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijantimicag.2011.05.012","article-title":"Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages","volume":"38","author":"Borborema","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.msec.2020.110720_bb0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dkh281","article-title":"Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine","volume":"54","author":"Tempone","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.msec.2020.110720_bb0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2020.110720_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5593","article-title":"Alarmin S100A8\/S100A9 as a biomarker for molecular imaging of local inflammatory activity","volume":"5","author":"Vogl","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msec.2020.110720_bb0340","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00436-015-4890-4","article-title":"Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB\/c mice","volume":"115","author":"da Silva","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.msec.2020.110720_bb0345","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.7871422","article-title":"Liposomes revisited","volume":"267","author":"Lasic","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.msec.2020.110720_bb0350","first-page":"3765","article-title":"Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue increased microvascular permeability contributes to preferential accumulation of","volume":"53","author":"Wu","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.msec.2020.110720_bb0355","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2017.11.028","article-title":"Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration","volume":"535","author":"Franz\u00e9","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and cutaneous delivery using nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2020.110720_bb0365","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1039\/C6CS00409A","article-title":"Lipid-based nanovesicles for nanomedicine","volume":"45","author":"Grimaldi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.msec.2020.110720_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0005-2736(02)00401-7","article-title":"Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements","volume":"1564","author":"Cevc","year":"2002","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.msec.2020.110720_bb0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S0033583508004721","article-title":"Interactions of surfactants with lipid membranes","volume":"41","author":"Heerklotz","year":"2008","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.msec.2020.110720_bb0380","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1208\/s12249-015-0441-7","article-title":"Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin","volume":"17","author":"Abdellatif","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.msec.2020.110720_bb0385","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2006.05.027","article-title":"Deformable liposomes and ethosomes as carriers: mechanism of enhanced skin delivery","volume":"322","author":"Elsayed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.110720_bb0390","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/616810","article-title":"Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes","volume":"2013","author":"Ghanbarzadeh","year":"2013","journal-title":"Biomed. Res. Int."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311832486X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311832486X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:59:42Z","timestamp":1760533182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092849311832486X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":78,"alternative-id":["S092849311832486X"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2020.110720","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2020.110720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110720"}}